[Comparative human studies of a new anti-hypertensive drug (2,6-dichloro-benzylidene-aminoguanidine acetate) and methyldopa in hypertensive patients].
A between-patients trial between a new anti-hypertensive drug (Guanabenz) and methyldopa in subjects with essential hypertension showed the new preparation to be active and endowed with a satisfactory therapeutic index.
D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006143:Guanabenz / Q000627:therapeutic use*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D008875:Middle Aged
D006146:Guanidines; D008750:Methyldopa; D006143:Guanabenz
Confronto tra pazienti di un nuovo anti-ipertensive (2,6-dicloro-benziliden-amino-quanidina acetato con metildopa in pazienti ipertesi